Chronic myeloid leukaemia [CML], BCR/ABL-positive

CML

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 C92.1
Hospital discharge: ICD-9 2051
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 C92.1
Cause of death: ICD-9 2051
Cause of death: ICD-8 $!$

-

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector

Include endpoints None

213

diagram downward connector
CML

Extra metadata

First used in FinnGen datafreeze DF2, additional

Summary Statistics

Key figures

All Female Male
Number of individuals 213 101 112
Unadjusted prevalence (%) 0.06 0.05 0.07
Mean age at first event (years) 56.56 55.61 57.41

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: CML – Chronic myeloid leukaemia [CML], BCR/ABL-positive
GWS hits:

Survival analyses between endpoints

Plot

before Chronic myeloid leukaemia [CML], BCR/ABL-positive
after Chronic myeloid leukaemia [CML], BCR/ABL-positive

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Chronic myeloid leukaemia [CML], BCR/ABL-positive